At a glance
- Originator Leiras Oy
- Developer Leiras Oy; Nonindustrial source
- Class Antirheumatics; Bisphosphonates; Calcium regulators; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bone disorders; Rheumatoid arthritis
Most Recent Events
- 19 Sep 2000 No-Development-Reported for Bone disorders in Scandinavia (PO)
- 19 Sep 2000 No-Development-Reported for Rheumatoid arthritis in Finland (IM)
- 29 Jun 1998 Investigation in Bone disorders in Scandinavia (PO)